1.
J Am Acad Dermatol
; 89(2S): S36-S39, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37591565
RESUMO
Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.
Assuntos
Alopecia , Finasterida , Humanos , Alopecia/tratamento farmacológico , Finasterida/uso terapêutico , Terapia Comportamental , Minoxidil/uso terapêutico , Suplementos Nutricionais
2.
3.
Dermatology
; 240(3): 517-518, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38228102
4.